VUMC researchers have secured a funding extension from the Advanced Research Projects Agency for Health (ARPA-H) to expand use of an artificial intelligence-guided platform for extracting and organizing critical information from unstructured clinical notes and reports in medical records.
New research from VUMC, reported in Alzheimer’s & Dementia by Corey Bolton, PsyD (Geriatric Medicine) and colleagues, shows that Alzheimer’s disease blood tests now arriving on the market might produce inaccurate results in the one-third of older adults who have kidney impairment, notably including those with only mild impairment.
A multidisciplinary team led by investigators at Vanderbilt University Medical Center has received a $4.2 million grant from the National Cancer Institute (NCI) to probe the genetics of colorectal adenomas. Xingyi Guo, PhD, associate professor of Medicine in the Division of Epidemiology, is lead principal investigator for the project.
Clinicians and scientists from around the world recently attended a symposium at Vanderbilt University Medical Center to honor the 75th birthday of Dan Roden, MD (Genetic Medicine and Clinical Pharmacology), a pioneer in personalized medicine and beloved colleague, mentor and friend.
Annet Kirabo, DVM, MSc, PhD, associate professor of Medicine (Genetic Medicine and Clinical Pharmacology), has been apppointed director of the Federation of Clinical Immunology Societies Center of Excellence (FCE) at VUMC. Rachel Bonami, PhD, assistant professor of Medicine (Rheumatology and Immunology), will serve as associate director of the Vanderbilt FCE.
Among those advocating on Capitol Hill were three Department of Medicine faculty, Drs. Alvin Powers (Diabetes, Endocrinology and Metabolism), Patrick Hu (Hematology and Oncology) and Hyun Song (Cardiovascular Medicine).
The three-year program will be led by Drs. Missy Scalise and Kaylin Craig, and will focus on training general internal medicine physicians with an emphasis on primary care.
Gitanjali Srivastava, MD, Professor of Medicine (Diabetes, Endocrinology and Metabolism), is clinical leader of a new, two-year, $1 million grant from Eli Lilly and Company that will seek to understand and address gaps in obesity care.
